- Home
- FRGT vs TOVX Comparison
FRGT vs TOVX Comparison
Compare FRGT & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- TOVX
- Stock Information
- Founded
- FRGT 2015
- TOVX 2001
- Country
- FRGT Mexico
- TOVX United States
- Employees
- FRGT N/A
- TOVX N/A
- Industry
- FRGT Professional Services
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- FRGT Consumer Discretionary
- TOVX Health Care
- Exchange
- FRGT Nasdaq
- TOVX Nasdaq
- Market Cap
- FRGT 3.5M
- TOVX 3.8M
- IPO Year
- FRGT N/A
- TOVX 2006
- Fundamental
- Price
- FRGT $0.83
- TOVX $0.28
- Analyst Decision
- FRGT
- TOVX Hold
- Analyst Count
- FRGT 0
- TOVX 1
- Target Price
- FRGT N/A
- TOVX N/A
- AVG Volume (30 Days)
- FRGT 7.4M
- TOVX 44.2M
- Earning Date
- FRGT 11-18-2025
- TOVX 11-11-2025
- Dividend Yield
- FRGT N/A
- TOVX N/A
- EPS Growth
- FRGT N/A
- TOVX N/A
- EPS
- FRGT N/A
- TOVX N/A
- Revenue
- FRGT $12,693,870.00
- TOVX N/A
- Revenue This Year
- FRGT $371.03
- TOVX N/A
- Revenue Next Year
- FRGT N/A
- TOVX N/A
- P/E Ratio
- FRGT N/A
- TOVX N/A
- Revenue Growth
- FRGT N/A
- TOVX N/A
- 52 Week Low
- FRGT $0.78
- TOVX $0.26
- 52 Week High
- FRGT $13.96
- TOVX $2.08
- Technical
- Relative Strength Index (RSI)
- FRGT 29.09
- TOVX 41.23
- Support Level
- FRGT $0.78
- TOVX $0.26
- Resistance Level
- FRGT $0.87
- TOVX $0.29
- Average True Range (ATR)
- FRGT 0.13
- TOVX 0.06
- MACD
- FRGT -0.03
- TOVX -0.00
- Stochastic Oscillator
- FRGT 2.73
- TOVX 2.19
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.